support from the National Natural Science Foundation of China(Nos.22277110 and 82003585)and Tianjian Laboratory of Advanced Biomedical Sciences.
Lenacapavir,also known as GS-6207,under the brand name Sunlenca,was developed by Gilead Sciences Inc.It has been approved in the EU,Canada,and US for use alongside other antiretrovirals in adults with multidrug-resist...
sponsored by grants from the National Natural Science Foundation of China(No.82030117);the Wenzhou major scientific and technological innovation project(No.ZY2022001).
Objective Melittin and its derivatives have been characterized to establish effective gene delivery systems.Their capability of facilitating endosomal release enhances the nanoparticles-based gene delivery.Nevertheles...
supported by the Strategic Priority Research Program (XDB29010000);National Key Research and Development Program (2018YFA0900801);National Science Foundation Grants 32200135 and 12034006;supported by National Science Fund for Distinguished Young Scholar (No.32325004);the NSFS Innovative Research Group (No.81921005);supported by the Young Elite Scientists Sponsorship Program by CAST (2022QNRC001);the Youth Innovation Promotion Association of CAS grant;supported by the Special Research Assistant Project of the Chinese Academy of Sciences.
Varicella-zoster is a highly communicable virus that can be transmitted through the airborne route.About one quarter of people are infected with this virus.Previous studies have described the structure of A-capsid and...
supported by Ministry of Science and Technology of China(2019YFA0903803 and 2018YFA0801404);National Natural Science Foundation of China(31871090,32000730,81961128019,and 81901397);Shenzhen Science and Technology Innovation Commission(JCYJ20190809171003698,JCYJ202103243001018,JCYJ20180507182505475,and JCYJ20180504165804015);Shenzhen Technological Research Center for Primate Translational Medicine(F-2021-Z99-504979);Youth Innovation Promotion Association(CAS 2017120);Chinese Academy of Sciences International Partnership Program(172644KYSB20170004);China Postdoctoral Science Foundation(2019M653115.);CAS Key Laboratory of Brain Connectome and Manipulation(2019DP173024);Guangdong Provincial Key Laboratory of Brain Connectome and Behavior(2017B030301017);International Science and Technology Cooperation Base of Guangdong Province(2019A050505008).
Retrograde adeno-associated viruses(AAVs)are capable of infecting the axons of projection neurons and serve as a powerful tool for the anatomical and functional characterization of neural networks.However,few retro-gr...
supported by the UK Medical Research Council(MR/W001241/1 to A.F.);the Canadian Institute of Health Research(PJT-178127 to A.F.);the Francis Crick Institute(to I.A.T.),with core funding from Cancer Research UK(CC2029);the UK Medical Research Council(CC2029);the Wellcome Trust(CC2029).
Lenacapavir,targeting the human immunodeficiency virus type-1(HIV-1)capsid,is the first-in-class antiretroviral drug recently approved for clinical use.The development of Lenacapavir is attributed to the remarkable pr...
financial support from the National Natural Science Foundation of China(NSFC Nos.82173677,82211530493);the Science Foundation for Outstanding Young Scholars of Shandong Province(No.ZR2020JQ31).
Despite the improving coverage of preventative vaccines,hepatitis B remains a severe global public health problem,with more than 250 million patients living with hepatitis B virus(HBV)infection.Current available thera...
supported by National Natural Science Foundation of China (82072270 and 82272306);Taishan Scholars Program (tstp20221142);Shandong Provincial Natural Science Foundation (ZR2021QC095);Academic Promotion Programme of Shandong First Medical University (2019LJ001).
Chikungunya virus(CHIKV)is a re-emerging mosquito-transmitted RNA virus causing joint and muscle pain.To better understand how CHIKV rewires the host cell and usurps host cell functions,we generated a systematic CHIKV...
the National Natural Science Foundation of China,China(Grant Nos.81925036 and 81872814);the Key Research and Development Program of Science and Technology Department of Sichuan Province,China(Grant No.2020YFS0570);111 project,China(Grant No.B18035);the Fundamental Research Funds for the Central Universities,China。
Due to the insufficient long-term protection and significant efficacy reduction to new variants of current COVID-19 vaccines,the epidemic prevention and control are still challenging.Here,we employ a capsid and antige...